Welcome to our dedicated page for Akerna news (Ticker: KERN), a resource for investors and traders seeking the latest updates and insights on Akerna stock.
Akerna Corp. (symbol: KERN) is a forward-thinking technology company specializing in software solutions for the cannabis industry. Established in 2010, the company has rapidly grown to become an industry leader, offering comprehensive data and consulting services tailored specifically for cannabis businesses. Akerna's flagship technology, MJ Freeway®, processes over $5 billion in cannabis sales transactions and serves clients across the United States, Canada, Europe, and Australia.
The core of MJ Freeway's offerings is a patented seed-to-sale supply chain ERP platform. This platform leverages sophisticated business intelligence insights to help cannabis businesses manage their operations more efficiently and stay compliant with regulatory requirements. Additionally, MJ Freeway's Leaf Data Systems technology empowers governments to monitor cannabis production and distribution, preventing diversion and ensuring the safety of patients, the public, and products.
In terms of consulting, MJ Freeway offers a complete suite of services designed to assist cannabis businesses in optimizing their operations, from initial setup to scaling their ventures. These consulting services provide expert guidance on navigating the complexities of the cannabis industry, ensuring that businesses are well-positioned for success.
Recently, Akerna has embarked on a series of strategic moves to enhance its market presence. Notably, the company is involved in proposed transactions with Gryphon Digital Mining, Inc. and MJ Acquisition Co. These transactions are expected to close around January 31, 2024, subject to necessary approvals and conditions. Gryphon Digital Mining is a notable player in the Bitcoin space, focusing on integrating digital assets into the clean energy grid with a net carbon-negative strategy.
Financially, Akerna remains committed to managing its operational expenses and navigating the costs associated with these proposed transactions. The company actively engages with investors and stakeholders, providing transparency through regular filings with the U.S. Securities and Exchange Commission (SEC).
For more information about Akerna Corp. and its innovative solutions for the cannabis industry, visit their official website at Akerna.com or contact their Investor Relations department at (516) 419-9915.
Akerna (Nasdaq: KERN) will announce its financial results for the fiscal quarter ending September 30, 2020, on November 12, 2020, complemented by a conference call at 8:30 AM ET. The company, known for its seed-to-sale ERP software, has tracked over $20 billion in cannabis sales. Investors can access the call via dial-in or a live webcast. The replay will be available until November 26, 2020. Interested participants can join Akerna's email distribution list for updates.
Akerna (Nasdaq: KERN) announced that CEO Jessica Billingsley has been appointed to Marijuana Business Daily's Advisory Board. Expressing her excitement, Billingsley aims to leverage her experience to guide data-driven decisions within the cannabis industry. Akerna, a leader in compliance technology and seed-to-sale ERP software, has tracked over $20 billion in cannabis sales. This appointment highlights Billingsley's industry influence, as she was previously named among Fortune's Most Promising Female Entrepreneurs and recognized for her leadership in cannabis technology.
Akerna Corp. (Nasdaq: KERN) has successfully closed a public offering of 5 million shares at $2.40 each, generating approximately $12 million in gross proceeds. After fees, the company will net around $11 million, intended for growth initiatives including product development, sales, marketing, and strategic acquisitions. The offering was facilitated by A.G.P/Alliance Global Partners and is documented in a registration statement filed with the SEC. Akerna focuses on providing compliance technology in the cannabis industry, having tracked over $20 billion in sales.
Akerna Corp. (Nasdaq: KERN) has announced a public offering of 5,000,000 shares of common stock at $2.40 per share, aiming for gross proceeds of approximately $12 million. After fees, the net proceeds are expected to be around $11 million, which the company intends to use for growth initiatives including product development, sales and marketing, and general corporate purposes. The offering is set to close on or about October 30, 2020, subject to market conditions. This follows a registration statement filed with the SEC on October 8, 2020.
Akerna (Nasdaq: KERN) released a report analyzing cannabis consumer trends in North America, revealing that consumers spend an average of $105.81 per transaction, with a basket size of 2.92 products. Cannabis flower leads sales at 46.2%, followed by vape cartridges at 31.6%. Notably, men constitute 63.5% of consumers, and nearly 42% are over 40 years old. Medical cannabis users spend more than adult-use users, with average ticket sizes of $118.55 and $69.70, respectively. The insights aim to help businesses optimize their sales strategies.
Akerna (Nasdaq: KERN) has launched MJ Retail, a groundbreaking point-of-sale software designed for the cannabis industry. This innovation allows dispensaries using MJ Freeway to expedite customer checkouts on any device. As the cannabis market grows, particularly post-pandemic, MJ Retail aims to enhance the customer experience by providing a user-friendly yet feature-rich solution. Existing MJ Platform customers can upgrade for free, while CBD businesses can access MJ Retail at no cost when signing up for MJ Payments. Akerna's robust platform has tracked over $20 billion in cannabis sales since 2010.
Akerna (Nasdaq: KERN) predicts a significant boost in cannabis sales for the Halloween weekend, forecasting an overall revenue generation of approximately $103 million. On October 30, adult-use sales are expected to increase by 11%, while Halloween itself is projected to see a 14% rise in adult-use sales. Medical cannabis sales are also anticipated to grow by 5% on Halloween. The average ticket sizes are projected at $74.48 for adult use and $124.43 for medical. Historically, Halloween ranks as the 5th largest cannabis sales day annually.
Akerna (Nasdaq: KERN) announced that its MJ Freeway consulting clients have secured the only two medical cannabis dispensary licenses in Iowa. The awarded clients are Iowa Cannabis Company East and Cannabis Patient Network. The consulting team boasts over 30 years of experience and has previously won licenses in competitive markets across 17 states. With upcoming legalization measures in several states, Akerna is positioned to assist clients in capitalizing on emerging opportunities in the cannabis industry.
On October 7, 2020, Akerna (Nasdaq: KERN) announced a partnership between its subsidiary, solo sciences, and Legion of Bloom, a leading California cannabis producer. The collaboration will introduce solo*CODE authentication tags to Legion's vaporizer products, enhancing product authenticity and consumer safety in California's $3.1 billion cannabis market. This initiative aims to combat counterfeit products, leveraging a coalition of California cannabis leaders while promoting environmental causes through product sales. The technology is designed to provide verifiable proof of product authenticity, ensuring consumer trust.
Akerna (Nasdaq: KERN) has released new business intelligence from its MJ Platform, revealing consumer preferences in cannabis strains for 2020. Indica-dominant strains topped sales at 37%, followed by Hybrid at 35%, and Sativa at 28%. First-time users prefer Hybrid strains (40%), while returning users favor Indica. Insights by gender show men prefer Indica (38%), while women lean towards Hybrid (37%). Age differences highlight that those under 30 prefer Hybrid, while older groups favor Indica. Market data from MJ Platform provides critical insights for operators and investors.
FAQ
What is the market cap of Akerna (KERN)?
What is Akerna Corp.?
What is MJ Freeway?
Where does Akerna operate?
What are Akerna's recent achievements?
What consulting services does Akerna offer?
What is Leaf Data Systems?
How does Akerna support regulatory compliance?
What are the details of Akerna's proposed transactions?
How can investors obtain more information?